Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00106392 · ClinicalTrials.gov registry record · Phase 4

A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

A Phase 4 study of Prostate Cancer and Erectile Dysfunction, sponsored by Astellas Pharma.

Completed
Registry status
Phase 4
Development phase
131
Enrollment target
6
Study locations

NCT00106392 is a Phase 4 study of Prostate Cancer and Erectile Dysfunction that has completed, run by Astellas Pharma. The registered enrollment target is 131 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (78% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00106392, a Phase 4 study of Prostate Cancer and Erectile Dysfunction, has completed, sponsored by Astellas Pharma.

COMPLETED
Registry status
Phase 4
Development phase
131 participants
Enrollment target
6
Study locations

Study Summary

The purpose of the study is to compare the safety and effectiveness of Prograf in the prevention of erectile dysfunction in men after a radical prostatectomy.

Conditions Studied

Prostate Cancer Erectile Dysfunction

Interventions

  • DRUG Placebo
  • DRUG Tacrolimus

Study Locations (6)

New York

  • - New York
  • - New York

Michigan

  • - Ann Arbor

Ohio

  • - Cleveland

Tennessee

  • - Nashville

Texas

  • - Houston

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2005-02
Est. Completion 2008-11
Phase Phase 4

Sponsor

Astellas Pharma

165 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00106392

The ClinicalTrials.gov registry entry for NCT00106392 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (78% lower). The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00106392 reports 6 study locations spanning 5 distinct geographic areas - top geographies include New York, Michigan, Ohio.

Frequently Asked Questions

What is clinical trial NCT00106392 about?

NCT00106392 is a clinical study titled "A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy". The purpose of the study is to compare the safety and effectiveness of Prograf in the prevention of erectile dysfunction in men after a radical prostatectomy.

What is the current status of trial NCT00106392?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 131 participants. The study started on 2005-02. Estimated completion is 2008-11.

What conditions does trial NCT00106392 study?

This clinical trial studies the following conditions: Prostate Cancer, Erectile Dysfunction.

What interventions are being tested in trial NCT00106392?

The interventions under investigation include: Placebo (DRUG), Tacrolimus (DRUG).

Who is sponsoring clinical trial NCT00106392?

This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00106392 being conducted?

This trial has 6 study locations across Michigan, New York, Ohio, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Erectile Dysfunction

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.